In this episode of Health 360, we discuss the rise of obesity in India as the number of obese people is expected to reach 450 million. Obesity has also triggered a rise in the popularity of ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Mangoes, a beloved summer treat, can pose health risks, especially for diabetics. Experts advise moderation, suggesting ...

India faces a growing liver disease crisis linked to obesity and diabetes, affecting even non-drinkers. Experts warn that ...

Dr Chris Palmer explains how eating more processed foods can harm your mental health, with a direct link between diet and ...

EXCLUSIVE: Dr Scott Miller has addressed the serious issue of pet obesity as he offers advice to concerned owners who may ...

As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

When people following a low-carb diet were grouped by how much total fat they ate, further patterns emerged regarding their ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...